Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2022 | Considerations for researching pharmacological management of pediatric cancer

Vanessa McLelland • 4 Oct 2022
BOPA 2022
General

Vanessa McLelland, MPharm, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK, discusses the effects of international collaboration on a recent trial for the pharmacological management of pediatric cancer. This interview took place at the British Oncology Pharmacy Association (BOPA) 2022 Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Vanessa McLelland

1:19
Optimizing treatment protocols for young adult patients with cancer
Vanessa McLelland • 9 Oct 2023
0:39
Challenges of treating young adult cancer patients
Vanessa McLelland • 4 Oct 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals